The Hormone replacement therapy method of alleviating and adjusting to menopausal symptoms is widely used for women entering menopause because of several reasons, health wise and general safety. The research by Thompson et al. (2017) revealed that the compounded biomedical hormone replacement therapy is preferred because more pushes draw them away from the hormone therapy and stronger pulls towards hormone replacement therapy.
One of them is the fear and uncertainty about the safety of the previously used hormone therapy. Women do not trust the side effects of hormone therapy, which outweighs their benefits. Another primary reason for the use of hormone replacement therapy is a strong distaste for conjugated estrogens. The fact that hormone therapy is manufactured from different things including animal urine makes it unpalatable. Women also do not trust the biomedical and the pharmaceutical industry producing the drug.
Delegate your assignment to our experts and they will do the rest.
Women, therefore, use hormone replacement therapy because the management of its symptoms is effective. The CHBT is more effective especially to women who have severe symptoms than conventional therapy. CHBT is also considered safe because it is plant based and is easily recognized by the body (Krieger et al. 2005). Women also desire to have individualized treatment; hence the CHBT suits their ambitions. The administration of the drug is through blood and saliva and can easily be individualized to their desired preferences. It is also tuned to their bodies more than hormone therapy. Another significant reason is that CHBT involves an enhanced clinical experience. The clinicians and the compound pharmacists who give enough time to their clients to explain themselves create trust between them and the women. The drug use involves counselling and follow-up activities hence good relationship and promotion of the hormone replacement therapy as well.
Reference
Krieger, N., Löwy, I., Aronowitz, R., Bigby, J., Dickersin, K., Garner, E., ... & Missmer, S. A. (2005). Hormone replacement therapy, cancer, controversies, and women’s health: historical, epidemiological, biological, clinical, and advocacy perspectives. Journal of Epidemiology & Community Health , 59 (9), 740-748
Thompson, J. J., Ritenbaugh, C., & Nichter, M. (2017). Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making. BMC women's health, 17(1), 97.
